NVDA vs UNH: Which Is the Better Buy?

Side-by-side comparison of NVIDIA Corporation and UnitedHealth Group Incorporated β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
NVIDIA Corporation Β· Technology
$182.08
+59.3% upside to fair value
High Conviction Grade A-
VS
UnitedHealth Group Incorporated Β· Healthcare
$304.33
+41.3% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NVDA has more upside to fair value (+59.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NVDA UNH
Current Price $182.08 $304.33
Fair Value Estimate $290.00 $430.00
Upside to Fair Value +59.3% +41.3%
Market Cap $4,425.5B $276.2B
Forward P/E β€” 15.1x
EV / EBITDA 31.4x 14.3x
Price / Sales 21.0x 0.6x
Price / FCF 46.9x 17.2x
Revenue Growth YoY +65.5% +11.8%
Gross Margin 71.1% 18.5%
Operating Margin 60.4% 4.2%
Return on Equity 76.3% 12.7%
Dividend Yield 0.02% 2.9%
FCF Yield 2.13% 5.82%
Analyst Consensus Strong Buy Buy
Investment Thesis
NVDA β€” NVIDIA Corporation
NVIDIA is the foundational infrastructure layer of the AI era. Data Center revenue reached $193.7B in FY2026, up 66% YoY, powered by insatiable demand for Blackwell B200 GPUs across hyperscalers and sovereign AI programs. The company generates $96.7B in annual free cash flow with 71% gross margins and 56% net margins, making it the most profitable semiconductor business in history. At P/E 37.7x v…
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
Accumulation Zones
Metric NVDA UNH
Zone Low $218.00 $280.00
Zone High $250.00 $340.00
In Buy Zone? Yes Yes
← NVDA Research    UNH Research β†’    All Research